ALPHARETTA, Ga., Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS ...

Q3 2024 Earnings Call Transcript October 30, 2024 Avanos Medical, Inc. misses on earnings expectations. Reported EPS is $ EPS ...

Avanos Medical Inc (AVNS) reports solid revenue and EBITDA growth, while addressing supply issues and strategic ...

ALPHARETTA, Ga., Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal ...

Avanos Medical, Inc. ( (AVNS) ) has realeased its Q3 earnings. Here is a breakdown of the information Avanos Medical, Inc. presented to its ...

The medical technology company posted revenue of $170.4 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $175 million. Avanos Medical expects full-year ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30 ...

Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 ...